Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease

Claire Bordat, Elie Nader, Philippe Connes, Philippe Joly, Solene Poutrel, Anne Perez, Eric Niesor

Open source

DOI
10.1177/13860291261475024
Published
2026-08-12
Container
Clinical Hemorheology and Microcirculation
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/13860291261475024,
  title = {Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease},
  author = {Claire Bordat and Elie Nader and Philippe Connes and Philippe Joly and Solene Poutrel and Anne Perez and Eric Niesor},
  year = {2026},
  journal = {Clinical Hemorheology and Microcirculation},
  doi = {10.1177/13860291261475024},
  url = {https://doi.org/10.1177/13860291261475024}
}

RIS

TY  - JOUR
TI  - Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease
AU  - Claire Bordat
AU  - Elie Nader
AU  - Philippe Connes
AU  - Philippe Joly
AU  - Solene Poutrel
AU  - Anne Perez
AU  - Eric Niesor
PY  - 2026
JO  - Clinical Hemorheology and Microcirculation
DO  - 10.1177/13860291261475024
UR  - https://doi.org/10.1177/13860291261475024
ER  - 

APA

Bordat, C., Nader, E., Connes, P., Joly, P., Poutrel, S., Perez, A., & Niesor, E. (2026). Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease. Clinical Hemorheology and Microcirculation. https://doi.org/10.1177/13860291261475024

Source records